<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140005260A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140005260</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>13730599</doc-number><date>20121228</date></document-id></application-reference><us-application-series-code>13</us-application-series-code><priority-claims><priority-claim sequence="01" kind="national"><country>TW</country><doc-number>101123339</doc-number><date>20120628</date></priority-claim></priority-claims><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>343</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>343</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>514469</main-classification></classification-national><invention-title id="d0e61">METHOD FOR INHIBITING CANCER METASTASIS BY AMIODARONE</invention-title><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Tsai</last-name><first-name>Huai-Jen</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Dai</last-name><first-name>Ming-Shen</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Ying-Shin</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Lee</last-name><first-name>Hung-Chieh</first-name><address><city>New Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>Lo</last-name><first-name>Hao-Chan</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>Su</last-name><first-name>Mei-Yan</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook><residence><country>TW</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Tsai</last-name><first-name>Huai-Jen</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Dai</last-name><first-name>Ming-Shen</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Ying-Shin</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Lee</last-name><first-name>Hung-Chieh</first-name><address><city>New Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Lo</last-name><first-name>Hao-Chan</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Su</last-name><first-name>Mei-Yan</first-name><address><city>Taipei City</city><country>TW</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>TRI-SERVICE GENERAL HOSPITAL</orgname><role>03</role><address><city>Taipei City</city><country>TW</country></address></addressbook></assignee><assignee><addressbook><orgname>NATIONAL TAIWAN UNIVERSITY</orgname><role>03</role><address><city>Taipei City</city><country>TW</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Amiodarone inhibits the invagination during zebrafish heart development and makes the defect on valves development. The present invention demonstrates that Amiodarone inhibits cancer metastasis and provides a method for inhibiting cancer metastasis in a subject in need thereof comprising administering to the subject a pharmaceutically effective amount of an Amiodarone or its salt.</p></abstract></us-patent-application>